Your browser is no longer supported. Please, upgrade your browser.
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
Teva Pharmaceutical Industries Limited
Index- P/E201.81 EPS (ttm)0.16 Insider Own2.70% Shs Outstand1.02B Perf Week1.89%
Market Cap31.99B Forward P/E6.53 EPS next Y4.79 Insider Trans0.00% Shs Float913.43M Perf Month-5.30%
Income68.00M PEG97.68 EPS next Q1.04 Inst Own63.10% Short Float2.35% Perf Quarter-6.23%
Sales21.90B P/S1.46 EPS this Y-96.10% Inst Trans-0.24% Short Ratio2.37 Perf Half Y-26.74%
Book/sh29.28 P/B1.07 EPS next Y-0.48% ROA0.10% Target Price40.13 Perf Year-41.82%
Cash/sh0.98 P/C32.06 EPS next 5Y2.07% ROE0.20% 52W Range30.22 - 55.04 Perf YTD-12.88%
Dividend1.36 P/FCF10.59 EPS past 5Y-53.00% ROI1.10% 52W High-42.36% Beta0.65
Dividend %4.35% Quick Ratio0.60 Sales past 5Y3.60% Gross Margin54.10% 52W Low5.00% ATR0.66
Employees56960 Current Ratio0.90 Sales Q/Q33.00% Oper. Margin9.80% RSI (14)45.35 Volatility2.20% 1.83%
OptionableYes Debt/Eq1.20 EPS Q/Q-284.70% Profit Margin0.30% Rel Volume0.44 Prev Close31.28
ShortableYes LT Debt/Eq1.09 EarningsMay 11 BMO Payout- Avg Volume9.07M Price31.73
Recom2.40 SMA20-0.35% SMA50-4.45% SMA200-21.55% Volume3,960,328 Change1.44%
Feb-28-17Downgrade Argus Buy → Hold
Feb-13-17Reiterated Maxim Group Hold $41 → $40
Feb-10-17Downgrade Mizuho Buy → Neutral $40 → $27
Jan-31-17Upgrade BofA/Merrill Neutral → Buy
Jan-31-17Reiterated Barclays Equal Weight $46 → $38
Jan-20-17Downgrade JP Morgan Overweight → Neutral
Jan-09-17Downgrade Wells Fargo Outperform → Market Perform
Jan-06-17Downgrade Maxim Group Buy → Hold $49 → $41
Jan-03-17Reiterated Maxim Group Buy $52 → $49
Dec-07-16Resumed Oppenheimer Outperform
Nov-16-16Reiterated RBC Capital Mkts Outperform $58 → $51
Nov-16-16Reiterated Mizuho Neutral $45 → $40
Nov-16-16Reiterated Maxim Group Buy $72 → $52
Nov-16-16Reiterated Deutsche Bank Buy $68 → $54
Nov-16-16Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-16-16Downgrade Jefferies Buy → Hold $69 → $40
Nov-14-16Resumed Barclays Equal Weight $46
Nov-14-16Reiterated RBC Capital Mkts Outperform $71 → $58
Nov-07-16Downgrade BofA/Merrill Buy → Neutral
Nov-04-16Downgrade HSBC Securities Buy → Hold
Apr-27-17 08:00AM  Teva Announces Publication of ARM-TD Study Results in Neurology® for the Investigational Use of Deutetrabenazine in Tardive Dyskinesia Business Wire
Apr-26-17 05:08PM  Merck cholesterol drug Vytorin faces competition from Impax, Teva generics Reuters
04:09PM  Teva Announces Launch of Generic Vytorin® in the United States Business Wire
01:12PM  Teva Confirms CFO Is Leaving
10:12AM  Finance chief quits drugmaker Teva, leaving another gap at top Reuters
09:02AM  Teva Announces Planned Departure of Eyal Desheh, Group Executive Vice President and Chief Financial Officer Business Wire
08:25AM  Short Sellers Cant Make Up Their Minds on Major Pharma 24/7 Wall St.
07:30AM  Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and TG Therapeutics Accesswire
06:05AM  Teva Said to Consider Sale of Cancer Portfolio to Reduce Debt Bloomberg
Apr-25-17 04:04PM  Express Scripts, Teva Pharmaceuticals Drop into Tuesdays 52-Week Low Club 24/7 Wall St.
03:08PM  Teva Pharmaceutical CFO Stepping Down
02:06PM  Teva Pharmaceutical CFO to step down: media Reuters
01:44PM  Mark Your Calendar For These Days In May To Play The Volatility Around FDA Decision Dates Benzinga
07:23AM  Teva looks to resume some production at Rimsa plant in Mexico Reuters
Apr-22-17 12:03PM  3 Dividend Stocks That Retirees Should Avoid Motley Fool
Apr-20-17 06:43PM  Teva's new asthma inhaler poses first competition for GSK's Advair Reuters
01:34PM  Teva launches copy of asthma inhaler Advair Reuters
08:42AM  Teva Launches AirDuo RespiClick® and its Authorized Generic, Two Inhalers Containing Fluticasone Propionate and Salmeterol Business Wire
Apr-19-17 08:00AM  Teva Showcases CNS Portfolio at 69th Annual Meeting of the American Academy of Neurology Business Wire
07:30AM  Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Valeant Pharmaceuticals Accesswire
Apr-18-17 07:11AM  The Billionaire And The Drug Price-Fixing Scandal Forbes
Apr-13-17 09:58AM  U.S. FDA raises concerns over Teva's plant in China Reuters
Apr-12-17 04:54PM  Neurocrine Avoids Suicide Warning In Teva-Rivaling Drug; Stock Pops Investor's Business Daily
04:04PM  Cenovus  Energy, DryShips Dip into Wednesdays 52-Week Low Club 24/7 Wall St.
01:40PM  Approval For Neurocrine's Ingrezza Was No Surprise, But Lack Of Warning Label A Big Advantage Over Teva Benzinga
12:57PM  Neurocrine Outperforms Even Bullish Estimates Of Ingrezza Approval Upside Benzinga
12:43PM  Why Neurocrine Biosciences Stock Is Soaring Higher Today Motley Fool
Apr-10-17 07:18PM  What Will Make Man Smarter?
Apr-07-17 03:19PM  Teva Pharmaceutical Said to Be Exploring Sale of Women's Health Unit
Apr-06-17 08:30AM  Teva to Report First Quarter 2017 Financial Results on May 11, 2017 Business Wire
Apr-05-17 03:36PM  Celgene (CELG) Gets Paragraph IV Notice Letter for Pomalyst Zacks
09:20AM  History Comes Back to Haunt Teva Pharmaceutical Industries, Sending Shares Down 8% in March Motley Fool
08:47AM  Why Teva stock isnt moving on its major Huntingtons disease drug approval MarketWatch
07:30AM  Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Neurocrine Biosciences Accesswire
07:24AM  An Israeli pharma firm has found a way to make drugs longer lasting and more effective Quartz
07:13AM  [$$] Teva Gets Good News but Still Needs a Head
12:26AM  [$$] Teva: Starting to Pierce the Gloom The Wall Street Journal
Apr-04-17 05:32PM  3 Stocks That Give Us Heartburn Motley Fool
04:36PM  Teva Pharma, Neurocrine Do Battle Over Neurological Treatments Investor's Business Daily
03:19PM  Huge Royals logo takes three strikes but wins approval in OP
12:35PM  [$$] Teva: Starting to Pierce the Gloom
11:44AM  Teva Pharmaceutical Receives FDA Approval For Huntington's Drug
10:39AM  Teva's Huntington's disease drug approved Monday, second drug ever approved for chorea
10:29AM  Teva Huntington's Drug Wins FDA Nod
08:45AM  Teva gets FDA OK for rare disease treatment
Apr-03-17 06:02PM  Teva wins FDA approval for Huntington's drug
05:04PM  Teva Announces FDA Approval of AUSTEDO (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntingtons Disease Business Wire
10:07AM  United Therapeutics loses challenge to its drug patent at
09:47AM  [$$] Teva investor warns of rebellion as pressure mounts at Financial Times
09:47AM  Teva Pharmaceutical Looks Vulnerable to Further Losses
09:06AM  Novartis Expects to Witness Flat Revenue Growth in 2017
02:00AM  Teva Receives Positive Outcome for COPAXONE® 40 mg/ml 3 Times Weekly Label in Europe Business Wire
Apr-01-17 11:05AM  Alan Knuckman's Teva Trade
Mar-31-17 04:32PM  Hat Tip: 5 Dividend Stocks that Should Hold Up if Market Tanks at
03:54PM  How to Trade Teva Pharmaceutical
03:54PM  How to Trade Teva Pharmaceutical
01:21PM  These Popular Stocks Could Prove Toxic for Your Portfolio at Motley Fool
12:25PM  Teva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : March 02nd, 2017 (record date) : By the numbers : March 31, 2017
Mar-30-17 09:16AM  Viagra May Be Soon Be Sold Without a Prescription in the UK at Investopedia
07:57AM  5 rock-solid dividend stocks to protect you from a stock-market retreat at MarketWatch
Mar-29-17 10:36AM  Performance of GlaxoSmithKlines HIV Business in 2016
07:37AM  GlaxoSmithKlines Pharmaceuticals Segment Performance
Mar-28-17 08:45PM  Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Biogen
Mar-27-17 07:00PM  Risk-Reward With Teva Pharmaceutical
08:35AM  Major Pharma Short Sellers Couldnt Make Up Their Minds Before Failed Trump Health Care Vote
Mar-24-17 10:54AM  Teva Pharma Denies Rumors of Global Workforce Reduction
Mar-23-17 10:16AM  Mylan Stock Dips On Recall Of 81,000 EpiPens Outside U.S.
09:06AM  Teva Denies Reports About 11% Global Workforce Reduction (TEVA) at Investopedia
06:52AM  Teva Pharm says media reports of up to 6,000 layoffs incorrect
04:30AM  Teva Pharm may fire 6,000 workers: Israeli media report
04:19AM  Teva Pharm may fire 6,000 workers -Israeli media report
03:33AM  Teva to Cut Undisclosed Number of Jobs as It Seeks to Pare Costs
03:33AM  Teva to Cut as Many as 6,000 Jobs, Calcalist Newspaper Reports
Mar-21-17 10:53AM  Nektar's Pain Drug Positive in Phase III Study; Shares Gain
Mar-20-17 08:10PM  Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Launches Minastrin Generic In The United States at Insider Monkey
10:32AM  AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal
Mar-17-17 09:58AM  Teva Launches Authorized Generic of Allergan's Minastrin
Mar-16-17 01:58PM  Teva Announces Launch of Authorized Generic of Minastrin® 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) in the United States Business Wire
Mar-14-17 07:02AM  3 High-Yield Investments in Healthcare at Motley Fool
Mar-13-17 11:18AM  Billionaire David Tepper Makes Huge Investments In These 4 Drug Stocks at Insider Monkey
11:00AM  Teva to Present at the Barclays Global Annual Healthcare Conference Business Wire
Mar-09-17 12:00PM  Why Battered Biotech Teva Is a Smart Contrarian Buy Right Now
Mar-08-17 01:52PM  The Tepper blitz on The Halftime Report
07:50AM  David Tepper's big bet in pharma
Mar-07-17 04:25PM  These Pharma Stocks Are Big Losers From Trump's Drug-Pricing Tweet
Mar-06-17 12:49PM  TD Ameritrade's Investor Movement Index (IMX) For February 2017
10:56AM  Teva to Present at the Cowen & Company 37th Annual Healthcare Conference Business Wire
Mar-05-17 11:41AM  3 Tempting Stocks to Avoid at Motley Fool
Mar-03-17 10:25AM  Perrigo Joins Firms With Generic Drugs Under U.S. Glare
06:00AM  Mylan's Governance May Be the Root of Its Problems
Mar-02-17 01:15PM  Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mylan N.V. (MYL) Accused Of Price Fixing By 20 More States at Insider Monkey
Mar-01-17 04:53PM  Twenty More States Accuse Mylan, Teva and Others of Price Collusion
10:56AM  Teva Announces Launch of Generic Pristiq® in the United States Business Wire
10:10AM  Priority Review Granted To Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Tardive Dyskinesia Drug at Insider Monkey
Feb-28-17 04:33PM  Teva Downgraded On Lost MS Drug Patents, DOJ Probe
08:55AM  Why Short Sellers Are Making a Massive Bet in Major Pharma
08:35AM  FDA to expedite review of Teva drug for movement disorder Reuters
08:00AM  Teva Announces Priority Review Granted by FDA for SD-809 for Treatment of Tardive Dyskinesia Business Wire
07:58AM  Teva Pharma downgraded by Argus
Feb-27-17 08:55AM  3 Surprising Big-Brand Stocks Billionaires Sold Heavily Last Quarter at Motley Fool
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the women's health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinson's disease; and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy and certain other disorders. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda/Bendeka, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. This segment also offers a portfolio of products in the women's health category, which includes ParaGard, Plan B One-Step, and OTC/Rx, as well as other products. The company has collaboration arrangements with Attenukine, Procter & Gamble Company, and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.